BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20166060)

  • 21. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
    Cazzola M; Floriani I; Page CP
    Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD002309. PubMed ID: 24190161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Tan DJ; White CJ; Wood-Baker R
    Cochrane Database Syst Rev; 2014 Dec; (12):CD006897. PubMed ID: 25491891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2013 May; (5):CD007891. PubMed ID: 23728670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents.
    Poole PJ; Black PN
    Am J Respir Med; 2003; 2(5):367-70. PubMed ID: 14719989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Airway clearance techniques for chronic obstructive pulmonary disease.
    Osadnik CR; McDonald CF; Jones AP; Holland AE
    Cochrane Database Syst Rev; 2012 Mar; (3):CD008328. PubMed ID: 22419331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Wang W; Morley C; Soltani A; Wood-Baker R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD006897. PubMed ID: 21975757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Li A; Chang AB
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WITHDRAWN: Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD004403. PubMed ID: 21249661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deoxyribonuclease for cystic fibrosis.
    Kearney CE; Wallis CE
    Cochrane Database Syst Rev; 2000; (2):CD001127. PubMed ID: 10796748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Gibson PG; Wood-Baker R; Hannay M; Walters EH
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001288. PubMed ID: 19160195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza vaccine for patients with chronic obstructive pulmonary disease.
    Poole PJ; Chacko E; Wood-Baker RW; Cates CJ
    Cochrane Database Syst Rev; 2000; (4):CD002733. PubMed ID: 11034751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled tiotropium for stable chronic obstructive pulmonary disease.
    Barr RG; Bourbeau J; Camargo CA; Ram FS
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002876. PubMed ID: 15846642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.